Background and Aim: This study evaluated the long-term outcome and prognostic factors of chronic hepatitis B, based on histological grade and stage. Methods: A total of 188 patients with chronic ...

Vir Biotechnology, a commercial-stage immunology company focused on ... HBV produces a surplus of viral antigens, including hepatitis B e antigen (HBeAg) and hepatitis B s antigen (HBsAg), which ...

Many individuals with chronic hepatitis B or C are unaware of their infection due to the asymptomatic nature of the disease in its early stages. Regular screening, particularly in high-risk ...

Hepatitis B virus is spread mostly by the transfer of ... of protective antibody responses in patients with diabetes or end-stage kidney disease who tend to respond poorly to traditional hepatitis ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

It happens in the late stage of liver disease and other conditions ... dysfunction-associated steatotic liver disease (MASLD), hepatitis, long-term alcohol use, and primary sclerosing cholangitis.